Jacob Chacko, President and CEO at Oric Pharmaceuticals, Inc. (ORIC), sold 11,892 shares at $25.05 ($298K) on 2021-09-14, disclosed to the SEC on 2021-09-16.
Open-market sale of $298k ORIC by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.05 | 4,420 | $111K | 37.2% |
| 2 | $25.06 | 3,736 | $94K | 31.4% |
| 3 | $25.06 | 3,736 | $94K | 31.4% |
| Total | $25.06 avg | 11,892 | $298K | 100% |
| Filing → |
| ORIC | SELL | 2025-10-02 | $2.1M | — | Filing → |
| ORIC | SELL | 2025-09-24 | $1.4M | — | Filing → |
| ORIC | SELL | 2024-12-17 | $408K | — | Filing → |